Impaired insulin action in the liver, but not in adipose tissue or muscle, is a distinct metabolic feature of impaired fasting glucose in obese humans
详细信息    查看全文
文摘
Elevated basal endogenous glucose production (EGP), impaired suppression of EGP by insulin and reduced insulin-stimulated glucose disposal are cornerstones of the pathogenesis of hyperglycemia in patients with type 2 diabetes. We aimed to determine the contribution of these processes to impaired fasting glucose (IFG) levels in obese non-diabetic adults.

Methods

We included 131 obese non-diabetic adults with normal fasting glucose levels (NFG; fasting glucose < 5.6 mmol/L; 62 men, 25 women; mean ± SEM age 49 ± 1 years; median (IQR) BMI 36 (34–41) kg/m2) or IFG (fasting glucose 5.6–6.9 mmol/L; 35 men, 9 women; age 53 ± 1 years; BMI 36 (34–42) kg/m2) and studied basal EGP and hepatic, adipose tissue and peripheral insulin sensitivity by two-step euglycemic hyperinsulinemic clamp studies with [6,6-2H2]glucose infusion.

Results

Compared to equally obese adults with NFG, individuals with IFG did not differ in basal EGP (9.1 ± 0.2 vs 9.8 ± 0.3 μmol kg− 1 min− 1, p = 0.082), insulin-mediated suppression of circulating free fatty acid levels (75 ± 1 vs 72 ± 3%, p = 0.240) and insulin-stimulated glucose disposal (26.6 ± 1.0 vs 25.2 ± 1.5 μmol kg− 1 min− 1, p = 0.441). Insulin-mediated suppression of EGP (68 ± 2 vs 55 ± 3%, p < 0.001) was markedly reduced in obese subjects with IFG.

Conclusions

Hepatic insulin resistance is a distinct metabolic feature of IFG in obesity. Insulin sensitivity of free fatty acid suppression and skeletal muscle does not differ between obese people with NFG and IFG. Hepatic insulin resistance may contribute to the onset of prediabetes in obese adults.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700